MTSS1 and hepatocellular carcinoma: Interestingly, most AFP negative patients (9 of 11, 81.8 %) showed higher MTSS1 mRNA levels in this study, suggesting that MTSS1 may be another early predictor of residual HCC, which merits investigation with a large group of patients.